These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33023502)

  • 1. Classification of gastrointestinal symptom patterns in young adults.
    Vivier H; Ross EJ; Cassisi JE
    BMC Gastroenterol; 2020 Oct; 20(1):326. PubMed ID: 33023502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Fukudo S; Nakaya K; Muratsubaki T; Nakaya N; Hozawa A; Bangdiwala SI; Palsson OS; Sperber AD; Kanazawa M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14581. PubMed ID: 37093785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.
    Vu J; Kushnir V; Cassell B; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2014 Sep; 26(9):1323-32. PubMed ID: 25070610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population.
    Lee AD; Spiegel BM; Hays RD; Melmed GY; Bolus R; Khanna D; Khanna PP; Chang L
    Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 27981684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Black CJ; Houghton LA; Ford AC
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Midenfjord I; Borg A; Törnblom H; Simrén M
    Am J Gastroenterol; 2021 Apr; 116(4):769-779. PubMed ID: 33982947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study.
    Clevers E; Whitehead WE; Palsson OS; Sperber AD; Törnblom H; Van Oudenhove L; Tack J; Simrén M
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1252-1259.e5. PubMed ID: 29510215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
    Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
    Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
    Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
    Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India.
    Goyal O; Nohria S; Dhaliwal AS; Goyal P; Soni RK; Chhina RS; Sood A
    Indian J Gastroenterol; 2021 Apr; 40(2):144-153. PubMed ID: 33226570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study.
    Polster AV; Palsson OS; Törnblom H; Öhman L; Sperber AD; Whitehead WE; Simrén M
    Neurogastroenterol Motil; 2019 Jan; 31(1):e13483. PubMed ID: 30393924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales.
    Khanna D; Hays RD; Shreiner AB; Melmed GY; Chang L; Khanna PP; Bolus R; Whitman C; Paz SH; Hays T; Reise SP; Spiegel B
    Dig Dis Sci; 2017 May; 62(5):1186-1192. PubMed ID: 28251500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity.
    Lackner JM; Gudleski GD; Thakur ER; Stewart TJ; Iacobucci GJ; Spiegel BM
    Am J Gastroenterol; 2014 Feb; 109(2):224-33. PubMed ID: 24419481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.
    Addante R; Naliboff B; Shih W; Presson AP; Tillisch K; Mayer EA; Chang L
    J Clin Gastroenterol; 2019 Apr; 53(4):e142-e149. PubMed ID: 29351154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
    Xiong LS; Shi Q; Gong XR; Cui Y; Chen MH
    J Dig Dis; 2014 Oct; 15(10):538-44. PubMed ID: 25102919
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.